Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Invite your friends, family, colleagues or clients to an exceptional black-tie event in the heart of London. Every ticket, every bid, every moment helps us move closer to a cure.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Professor Roman Hovorka wins prestigious award at Europe’s largest diabetes conference
Aaron Kowalski (JDRF International CEO), Karen Addington (JDRF UK CEO) and Professor Roman Hovorka
The EASD-Novo Nordisk Foundation Diabetes Prize for Excellence is awarded each year to a world-leading diabetes researcher from any country. This year’s winner is Professor Roman Hovorka from the University of Cambridge.
Roman was awarded this year’s prize at Europe’s largest diabetes conference, EASD, for his influential contributions to diabetes technology. With JDRF funding, he developed the world’s first licensed, downloadable HCL app for people with type 1 diabetes. Launched in 2020, the CamAPS FX app, allows the user’s insulin pump to deliver insulin in response to blood glucose readings from their continuous glucose monitor. Roman’s revolutionary approach to type 1 diabetes management continues to improve the lives of many people with type 1.
The award comes with prize money to fund Roman’s HCL research for up to five years. This will allow him to advance HCL technology and explore the potential for fully closed loop systems, which wouldn’t require any input or adjustments from the user.
Thanks to JDRF and our supporters, Roman developed a complex algorithm to automatically deliver insulin to people with type 1. With our ongoing funding, he led several trials of his HCL model, gathering evidence that people with type 1 as young as one year old benefit from HCL technology under a wide range of conditions.
Learn more about JDRF-funded hybrid closed loop research.
Karen Addington (CEO of JDRF UK) and Rachel Connor (Director of Research Partnerships) attended the ceremony where Professor Hovorka was awarded the esteemed prize.
Karen said: “I am absolutely delighted that Roman has won this award. I remember the excitement of the early days when JDRF first funded Roman’s work in 2006 as part of our first international closed loop consortium. The idea of a closed loop system seemed like science fiction at the time, but Roman and his team have exceeded all our expectations in creating a brilliantly effective closed loop system and making it available for people with type 1 diabetes. Congratulations Roman.”
Find out more about the NICE Technology Appraisal of hybrid closed loop technology.
Professor Hovorka isn’t the first UK-based JDRF-funded researcher to win the Prize for Excellence, demonstrating the strength of UK type 1 diabetes research. In 2021, Professor John Todd from the University of Oxford won the prestigious award for his research into the genetics and disease mechanisms underlying type 1 diabetes. Thanks to our dedicated supporters, we are able to fund the very best internationally recognised diabetes researchers.
We’re aware of growing concern around insulin supply in the UK, and we want to reassure our community that this is not a general insulin shortage. There is no need to change the type of insulin you use.
If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.
We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.
Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
